Guidance

Meningococcal disease enhanced surveillance plan

The national surveillance protocol for invasive meningococcal disease in England

From:
UK Health Security Agency
Published
28 August 2015
Last updated
15 December 2022 — See all updates

Applies to England

Documents

Meningococcal disease enhanced surveillance plan

Ref: UKHSA publication gateway number GOV-13866

PDF, 1.16 MB, 28 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Meningococcal disease surveillance flow chart (print version)

Ref: UKHSA publication gateway number GOV-13866

PDF, 318 KB, 1 page

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Meningococcal disease surveillance flow chart (text version)

HTML

Details

The national surveillance protocol for invasive meningococcal disease (IMD) in England has been extended in recognition of:

  • changes to the meningococcal group C conjugate (MCC) vaccination programme, including the removal of the infant MCC dose at 4 months and the introduction of an adolescent MCC dose in June 2013
  • the emergency introduction of a quadrivalent conjugate vaccine against meningococcal groups A, C, W, and Y (MenACWY) for 14 to 18 year olds in August 2015 in response to a national outbreak of a hypervirulent meningococcal group W (MenW)
  • the introduction of a meningococcal group B (MenB) vaccine, Bexsero®, into the national infant immunisation schedule in September 2015

The meningococcal disease enhanced surveillance plan flowchart has been compiled to summarise and clarify the actions required by UKHSA health protection teams following the report of a suspected case of invasive meningococcal disease.

Record suspected or confirmed cases of invasive meningococcal disease using the enhanced surveillance forms for healthcare professionals.

Updates to this page

Published 28 August 2015
Last updated 15 December 2022 + show all updates

  1. Updated surveillance plan and flow chart.

  2. Updated surveillance plan and flow chart.

  3. Updated surveillance plan and flow chart.

  4. Added the meningococcal surveillance flow chart.

  5. First published.

Sign up for emails or print this page

Related content